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Graphical Abstract 
 
 
Highlights 
 A multifunctional platform based on melanin (Mel)-decorated, hyaluronic acid 
(HA)-modified MoS2 sheets has been designed. 
 The formed nanoplatform with high DOX loading capacity and exhibited pH-
dependent and near-infrared laser-triggered DOX release. 
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 The synergetic effect in the enhancement of photothermal efficiency was 
achieved. 
 The engineered HPMP@(DOX/Mel) nanoplatform exhibits excellent 
synergistic chemo-photothermal effect for cancer therapy. 
 
Abstract 
Synergistic tumor treatment has recently attracted more and more attention due to its remarkable 
therapeutic effect. Herein, a multifunctional drug delivery system based on hyaluronic acid (HA) 
targeted dual stimulation responsive MoS2 nanosheets (HA-PEI-LA-MoS2-PEG, HPMP) for active 
interaction with CD44 receptor positive MCF-7 cells is reported. Melanin (Mel), a new type of 
photothermal agent and doxorubicin (DOX) are both loaded onto the HPMP nanocomposite and can 
be released by mild acid or hyperthermia. The prepared HPMP nanocomposite has a uniform 
hydrodynamic diameter (104 nm), a high drug loading (944.3 mg.g-1 HPMP), a remarkable 
photothermal effect (photothermal conversion efficiency: 55.3%) and excellent biocompatibility. 
The DOX release from HPMP@(DOX/Mel) can be precisely controlled by the dual stimuli of 
utilizing the acidic environment in the tumor cells and external laser irradiation. Meanwhile, loading 
of Mel onto the surface can enhance the photothermal effect of the MoS2 nanosheets. In vitro 
experiments showed that the HPMP@(DOX/Mel) nanoplatform could efficiently deliver DOX into 
MCF-7 cells and demonstrated enhanced cytotoxicity compared to that of the non-targeted 
nanoplatform. In vivo experiments in a breast cancer model of nude mice further confirmed that the 
HPMP@(DOX/Mel) significantly inhibited tumor growth under near infrared (NIR) laser 
irradiation, which is superior to any single therapy. In summary, this flexible nanoplatform, based 
on multi-faceted loaded MoS2 nanosheets, exhibits considerable potential for efficient pH/NIR-
responsive targeted drug delivery and chemo-photothermal synergistic tumor therapy. 
 
Keywords: MoS2 nanosheets; Targeted drug delivery; Melanin; Synergistic therapy; Enhanced 
photothermal therapy. 
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In recent years, the rapid development of new nanomaterials and nanotechnology has led to a 
research boom in effective treatment of tumors [1, 2]. Among various treatment strategies, 
chemotherapy has been considered as one of the most commonly used cancer treatment methods [3, 
4]. However, traditional chemotherapeutic agents exhibit several disadvantages such as poor water 
solubility, low cancer cells uptake efficiency, severe toxic side effects on normal cells, drug 
resistance and non-specific delivery [5, 6]. In order to overcome the shortcomings of these 
chemotherapeutic agents, extensive research has been conducted on various strategies including 
stimuli-responsive drug-targeted delivery systems [7, 8], enhanced chemotherapeutic drug cellular 
uptake [9] and different combinations of therapeutic regimens [10] to improve cancer treatment 
efficacy and reduce side effects.  
Photothermal therapy (PTT), as a minimally non-invasive treatment, has attracted widespread 
attention in the biomedical field in recent years [11]. PTT can effectively penetrate a few centimeters 
thick biological tissue and exhibit low tissue absorption [12, 13]. However, with the gradual 
attenuation of NIR laser in biological tissues over time, it is difficult to completely kill tumor cells 
by relying solely on PTT treatment [3]. Moreover, some of the photothermal agents currently 
reported have disadvantages such as high cost, relatively low photothermal stability, poor 
photothermal conversion efficiency [14] and potential toxic side effects [15]. In addition, it has been 
reported that PTT can not only ablate cancer cells in situ by hyperthermia, but the heat generated by 
nanoparticles can significantly improve the efficacy of chemotherapy drugs [16]. In summary, 
chemotherapy combined with photothermal therapy may be a promising strategy to improve cancer 
treatment efficiency and reduce side effects and avoid some of the drawbacks of current cancer 
chemotherapy and photothermal therapy because of its significant synergistic effect [17]. 
The so-called synergistic treatment combines some cancer treatment methods (such as 
chemotherapy, photothermal therapy, photodynamic therapy, etc.) to form a multifunctional 
nanoplatform to avoid deficiencies seen in a single therapy to improve effectiveness and optimize 
treatment [6, 18]. Recently, Teng et al. reported a PEG-modified MoS2 nanosheet system for 
combining photothermal therapy with chemotherapy [19] and Fei et al. reported nir-laser-controlled 
drug release from DOX/IR-780-loaded temperature-sensitive-liposomes for chemophotothermal 
synergistic tumor therapy [6]. In the current study, a stimulating responsive targeted drug delivery 
nanoplatform was constructed for the synergistic tumor chemotherapy and photothermal therapy by 
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combining the chemotherapeutic drug DOX with the photothermal agent MoS2 and Melanin with 
subsequent modification with hyaluronic acid [20-22 ]. 
Two-dimensional nanomaterials are widely used in the development of nano-devices or 
nanomedicines in the field of molecular biomedicine due to their ideal physical and chemical 
properties [23]. For example, two-dimensional transition metal disulfides (TMDCs) have attracted 
great interest from researchers due to their interesting electronic properties, high near-infrared 
absorption, and high specific surface area [19, 24-26]. As a typical representative of TMDCs, MoS2 
nanosheets have good photothermal properties and good biosafety, making them suitable candidates 
for next-generation photothermal therapeutics [5, 18, 26]. In particular, its constituent elements S 
and Mo are common biological trace elements [27, 28], thus MoS2 is an excellent material for 
biomedical applications. However, the high surface energy of a few layers of nanosheets tend to 
inevitably stack and aggregate, which limits the application severely [29, 30]. In addition, the 
colloidal stability of the prepared MoS2 nanosheet is limited, which is crucial for its application in 
the biomedical field [31]. In summary, it is necessary to develop a new type of MoS2-based 
nanoplatforms which show good photothermal properties and bio-safety.  
Our group previously conducted targeted drug delivery based on functionalized 
MoS2nanosheets and a combination of chemotherapy and photothermal therapy, but the 
photothermal effect of the nanomaterials requires further enhancement [30, 31]. Zhang et al. [32] 
reported a melanin (Mel) based liposome therapeutic diagnostic nanosystem with high biosafety 
and good therapeutic properties. Melanin is an endogenous bio-pigment in the human body with an 
intrinsic optical absorption capacity [33, 34]. The prepared Lip-Mel nanoliposomes have an ideal 
photothermal conversion efficiency, which can achieve complete killing of tumor cells of breast 
cancer-bearing mice. Consequently, due to its excellent photothermal properties and good 
biocompatibility, melanin is promising as a bio-safe photothermal nano-agent for photothermal 
ablation of tumors [35-39]. 
Polyethyleneimine (PEI), along with PEG, was used to modify the MoS2 nanosheets to afford 
HA-functionalized MoS2 nanosheets [28, 40-42]. The prepared HA-PEI-LA-MoS2-PEG (HPMP) 
nanocarrier serves as an active targeting multifunctional nanoplatform for: (1) CD44 high 
expression of MCF-7 cells [43]; (2) delivering DOX and pH/NIR-responsive DOX and melanin 
release; and (3) synergistic chemo-enhanced photothermal therapy. Conjugating the HA to MoS2 
J
ur
al 
Pr
-p
oo
f
6 
 
significantly enhanced the targeting efficiency in high CD44 receptor expressing MCF-7 cells.  
The combined loading of the chemotherapeutic drug DOX and the photothermal agent melanin in 
the nanocarriers enables the effective combination of chemotherapy and photothermal therapy to 
greatly improve the therapeutic effect on breast cancer cells. To the best of our knowledge, this is 
the first report of a MoS2 nanosheet-based nanoplatform that combines multifunctional element 
loading for the improvement of photothermal conversion and synergistic therapy and may constitute 
a new class of nanoplatform for highly effective treatment of tumors. 
 
Scheme 1. Schematic illustration of the multifunctional platform based on DOX and Mel co-loaded 
MoS2 nanosheets for targeted drug delivery and synergistic chemo-photothermal therapy of tumors. 
 
2. Materials and methods 
2.1. Materials 
Hyaluronic acid (HA, Mw=0.5kDa) was purchased from Tianjin Hines Oppod Technology Co., Ltd. 
(Tianjin, China); Melanin (Mel) was obtained from Beijing Keruimai Technology Co., Ltd. (Beijing, 
China) and mPEG-SH (Mw=2kDa) was acquired from Shanghai Gegeen Trade Department(Shanghai, 
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China).Poly(ethylene imine) (PEI, Mw=25 kDa), doxorubicin (DOX), N-[3-(dimethyl amino)propyl]-N'-
ethyl-carbodiimide hydrochloride (EDC), N-hydroxy succinimide (NHS), alpha-lipoic acid (LA), and n-
BuLi solution in hexane (2.4 M) were all purchased from Aladdin Biochemical Polytron Technologies 
Inc. (Shanghai, China). Acetonitrile was ordered from Tianjin Hines Oppod Technology Co., Ltd. 
(Tianjin, China); dimethyl sulfoxide (DMSO) was purchased from Sigma-Aldrich (St. Louis, MO, USA); 
and 3-(4,5-Dimethyl-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT), MoS2 powder was obtained 
from Sinopharm Chemical Reagent Co., Ltd. 4′-6-Diamidino-2-phenylindole (DAPI) was procured from 
Dalian Meilun Biotech Co., Ltd. (Dalian, China). MCF-7 and L929 cell lines were obtained from 
KeyGEN Bio TECH Co., Ltd. (Nanjing, China).  
 
2.2．Preparation of single-layer MoS2 nanosheets 
Single layer MoS2 nanosheets were synthesized by using a top-down approach as reported in the 
literature [18]. Specifically, MoS2 (2 g) was mixed with a solution of n-butyllithium in hexane (2 mL) 
and stirred for 2 d. Then, the reaction product was washed three times with an organic solvent hexane 
(10 mL), dispersed in purified water (30 mL) and the multilayered MoS2 nanosheets were fully exfoliated 
by sonication for 90 min. The supernatant was finally collected by centrifugation at 3000 rpm/min, and 
then re-dispersed in water and dialyzed against a cellulose membrane (MWCO: 10000) for 3 days to 
obtain single layer MoS2 nanosheets. Table S2 gives a summary of the different reaction conditions 
investigated and the best yield (51.6%) was obtained with 1.6 M n-buthyllithium and 90 min sonication. 
 
2.3. Functionalization of single-layer MoS2 nanosheets 
PEI (300 mg) was dissolved in deionized water (20 mL) and the pH was adjusted to 7.4 with dilute 
hydrochloric acid. LA (82.4 mg) was dispersed in an organic solvent acetonitrile (20 mL). Next, EDC 
(191.7 mg) and NHS (115.1 mg) were sequentially added to the LA solution, stirred for 30 min, and then 
the PEI solution was added and stirred for 12 h. The initial product, LA-PEI, was purified by dialysis 
using a dialysis bag (MWCO 1000). LA-PEI (30 mg) was then dispersed in water (10 mL) and MoS2 
(2.5 mg) in water (10 mL) was added and sonicated for 15 min. After stirring at room temperature for 12 
h, the resulting modified MoS2 nanosheets were placed in a dialysis bag (MWCO 3500) and dialyzed 
with deionized water. The PEGylation process was conducted to introduce a PEG layer onto the surface 
of PEI-LA-MoS2. mPEG-SH (25 mg) was added to a PEI-LA-MoS2 dispersion (10 mL; 0.5 mg mL-1) 
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and, after sonicating for 15 min, the mixture was stirred for 12h and the resultant product, PEI-LA-MoS2-
SH-PEG (PMP) was obtained by centrifugation and washed several times using water (10 mL) and 
ethanol (10 mL). 
 
2.4. Preparation of HA modified nanocomposites  
HA (30 mg) was dispersed in purified water (20 mL) and EDC (8 mg) dissolved in purified water (10 
mL) was added and sonicated for 15 min. An EDC solution (10 mL, 1 mg mL-1) and an NHS solution(15 
mL; 2 mg mL-1) was then added, the pH adjusted to about 8.5 and the mixture was stirred at room 
temperature for 2 h. Finally, PMP (15 mg) was added and the reaction mixture was stirred in the dark for 
12 h, the mixture was centrifuged at 10000 r/min for 15 min and the precipitate was washed 3 times with 
purified water to obtain HA-PEI-LA-MoS2-PEG (HPMP). 
 
2.5. Drug loading 
The HPMP nanocarrier and the chemotherapy drug DOX were mixed in different ratios and stirred 
overnight in the dark at pH=7.4 and the unloaded DOX were removed by centrifugation. The amount of 
DOX remaining in the supernatant was determined by ultraviolet absorption spectroscopy, thereby 
determining the optimal mass ratio of the drug. The HPMP was mixed with the model drug DOX 
according to a certain ratio (1:1) and stirred overnight, and the drug-loaded composite, HPMP@DOX, 
was collected by centrifugation. HPMP@DOX solution (10 mL) and of Mel solution  (10 mL, 
HPMP@DOX:Mel mass ratio of 5:1) were then mixed, stirred overnight and the precipitate was collected 
by centrifugation to obtain the final product HPMP@(DOX/Mel). The drug loading content of HPMP 
was calculated according to the following formula: 
Drug loading content of HPMP (%) =
total weight of DOX − weight of unloaded DOX
total weight of HPMP
× 100% 
2.6. Material characterization 
The morphologies and sizes of nanoparticles were measured using a JEM-2100F transmission 
electron microscope. Atomic force microscopy (AFM) was performed on a NanoScope IIIa from Veeco 
Instruments. Powder XRD patterns were performed on a Bruker D8 Advance X-ray diffractometer 
equipped with Cu Kα radiation (λ = 1.5418 Å). The chemical composition of the MoS2 nanosheets was 
measured by X-ray photoelectron (XPS) spectroscopy (Escalab 250Xi instrument). Zeta-potential 
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analyses were measured using a Nano Zeta sizer instrument. The particle size distribution was measured 
with dynamic light scattering (DLS, Brookhaven BI-200SM). FTIR spectra were obtained using a 
Nicolet 6700 FTIR spectrometer (Nicolet Instruments Inc, USA). The UV-vis-NIR spectra were recorded 
on a UV3600 spectrophotometer (Shimadzu Corporation) and the photothermal heating effect of the 
MoS2 particles were determined using an 808 nm laser (ADR-1860, Shanghai Xilong Optoelectronics 
Technology Co. Ltd.) at a wavelength of 808 nm. 
 
2.7. Photothermal effects 
The photothermal properties of the HPMP@(DOX/Mel) were evaluated by use of 808 nm laser 
irradiation (1.0 W cm-2, 5 min) at different concentrations of the nanocomposite. In addition, 
HPMP@(DOX/Mel) at a fixed concentration of 1.0 mg mL-1 was irradiated with various 808 nm laser 
power intensities, with HPMP being used as a control. Furthermore, in order to test photostability, the 
HPMP@(DOX/Mel) nanocomposites (200 μL; 1.0 mg mL-1) were irradiated for 10 min(power density: 
1.0 W cm-2). The experiment was carried out four times in succession and the temperature of the solution 
was simultaneously recorded every 5s using an infrared (IR) thermal imaging system. Also, the 
temperature of different samples was recorded using an FLIR Automation & Science Camera. The 
photothermal transduction efficiency of HPMP@(DOX/Mel) was measured by use of previously 
reported methodology [44] with some modification as shown in equations (2) and (3): 
η
T
=
hA(TMax − TSurr) − QD
I(1 − 10−A808)
(2)                          𝜏𝑠 =
𝑚𝐷𝐶𝐷
ℎ𝐴
(3) 
where h is the heat transfer coefficient, A is the surface area of the container, Tmax is the equilibrium 
maximum temperature, Tsurr is the surrounding ambient temperature, QD is heat absorption of the quartz 
cell, I is the laser power (250 mW), A808 is the absorbance of HPMP@(DOX/Mel) at 808 nm, τs is the 
system time constant and mD and CD are the mass (0.2 g) and the heat capacity (4.2 J g−1)of deionized 
water, respectively. 
 
2.8. In vitro drug release 
HPMP@(DOX) (2 mL;1 mg mL-1) dissolved in a PBS solution (pH 7.4 or pH 5.0) was put into a 
dialysis bag (Mw=6 KDa) and dialyzed in a beaker of PBS solution (50 mL) with different pH values 
with or without 808 nm laser irradiation (1 W cm-2). A sample (1 mL) of the PBS solution in the beaker 
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was taken at different time points and an equal amount of PBS solution was added. The cumulative 
release of drug DOX was measured at 480 nm using an ultraviolet spectrophotometer.  
 
2.9. Cell culture and cytotoxicity assays in vitro 
MTT was performed to assess the cytotoxicity of HPMP to normal cells (L929) and cancer cells 
(MCF-7). First, MCF-7 and L929 cells were treated with DMEM containing 1% penicillin and 1% 
streptomycin. Cells were seeded into 96-well plates at a density of 1 × 104 cells per sample. Different 
concentrations (1.5, 3, 6, 12 and 24 μg mL-1) of HPMP were then added to both cells and incubated for 
24 h at 37 °C in a 5% CO2 incubator. Next, MTT reagent (20 μL; 5 mg mL-1) was added, and after further 
incubation for 4 h, the supernatant was taken out, and the MTT-formazan produced in the cells was 
dissolved in an organic solvent DMSO (150 μL) for 15 min. Finally, the solution optical density was 
measured at 570 nm using a microplate reader (MULTSIKAN MK3, Thermo Fisher). 
To evaluate the potential of in vitro chemistry-photothermal synergistic therapy, MCF-7 cells were 
seeded in 96-well plates (density: 1×104), and cultured in an incubator at 37 °C, 5% CO2 for 24 h. Next, 
without/with the presence of 808 nm laser (power density: 1.0 W cm-2, 10 min), MCF-7 cells were 
incubated with various concentrations (1.5, 3, 6, 12, 24 μg mL-1) of free DOX，HPMP@DOX, 
HPMP@DOX+NIR, HPMP@Mel+NIR, PMP@(DOX/Mel)+NIR, and HPMP@(DOX/Mel)+NIR for 
36 h in DMEM. Then, after incubating for 4 h by adding MTT solution (20 μL, 5 mg mL-1), the 
supernatant was taken out, and MTT-methane produced by living cells was dissolved in an organic 
solvent DMSO (200 μL) for 20 min. Finally, the absorbance of each well solution was measured at 570 
nm on a microplate reader (MULTSIKAN MK3, Thermo Fisher). 
 
2.10. In vitro cellular uptake 
Tumor cell targeting performance of synthetic nanomaterials was studied by using confocal 
laser scanning microscopy (CLSM, Jena, Germany). MCF-7 cells (CD44 receptor positive) were 
seeded into 24-well plates at a density of 1 × 105 cells per well and cultured for 24 h. All cells were 
treated with free DOX, PMP@(DOX/Mel), HPMP@(DOX/Mel) and HPMP@(DOX/Mel) with 
laser irradiation for 30 min at an equivalent DOX concentration of 5.0 μg mL-1 for 4 h followed by 
washing the cells with PBS. After the cells were further cultured for 2 h, they were then washed and 
fixed with 4% formaldehyde solution (time: 30 min). Cancer cell nuclei were labeled with DAPI 
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and cell images were recorded by CLSM (,. 
 
2.11. In vivo infrared thermal imaging  
For thermal imaging in mice, first, nude mice bearing MCF-7 tumors were anesthetized with 
pentobarbital (1%) and injected with HPMP@DOX or HPMP@(DOX/Mel) solution (1.0 mg mL-1) into 
nude mice containing MCF-7 tumors by intravenous injection. A saline (200 μL) group was used as a 
control group. Next, mouse tumor sites were irradiated with 808 nm laser for in vivo thermography (0.8 
W cm-2, 8 min) and the temperature and IR thermal images of tumor sites were recorded at different time 
points using FLIR Automated & Scientific Camera. 
 
2.12. In vivo experiments 
Animal experiments were performed following protocols approved by the Institutional Animal Care 
and Use Committee of Nanjing Medical University and all the animals were treated in compliance with 
the Nanjing Maternity and Child Health Care Hospital’s guidelines. 4-6 week old nude mice were 
obtained from Nanjing Pengsheng Biotechnology Co., Ltd., and each mouse was inoculated with 1 x 106 
MCF-7 cells by subcutaneous injection. When the tumor size of the mice after MCF-7 cell inoculation 
was 50 mm3, the experimental mice were randomly divided into 5 groups of 3 each. Next, each mice was 
injected intravenously: saline (control), free DOX (3 mg kg-1), HPMP@(DOX/Mel) (chemotherapy), 
PMP@(DOX/Mel) + NIR or HPMP@(DOX/Mel)+ NIR (synergistic therapy). The tumor regions of the 
NIR groups were irradiated with 808 nm laser energy (1.0 W cm-2; 5 min) on the second day (at 24 h 
post-injection). Body weight and tumor volume were measured every 2 days after irradiation and the 
tumor volume was calculated according to the formula V = W2 × L/2, where W and L are the width and 
length diameters, respectively. 
 
2.13. Histological analysis 
After culturing the experimental mice for 25 days, representative mice of the five groups were killed. 
The tumor and the main organs of the body (heart, lung, spleen, liver and kidney) were excised from the 
experimental mice and a 4% paraformaldehyde solution was selected as a fixative and processed into 
paraffin sections. Finally, the main organs were stained with H&E and the tumor tissues were stained 
with H&E and TdT-mediated dUTP Nick-End Labeling (TUNEL) for histopathology analysis. 
 
Jo
urn
al 
Pre
-pr
of
12 
 
2.14. Statistical analysis 
Every experiment was performed three times and the results are presented as the mean SE ± SD. 
All statistical analyses were performed with Graph Pad Prism software and the significance of the data 
for all tests were analyzed using Student’s t test: *P < 0.05, **P < 0.01 and ***P < 0.001. 
 
3. Results and discussion 
3.1. Synthesis and characterization of nanocomposites 
Scheme S1 demonstrated the preparation strategy for HPMP nanoparticles (Supporting Information). 
Single-layered MoS2 nanosheets were synthesized by chemical exfoliation from multilayered MoS2 as 
described previously [18] which was optimized by varying the reaction conditions as shown in Table S2. 
The highest yield obtained reached 51.6%, which is close to the reported research [45]. As shown in 
Scheme S1a and S1b, LA-PEI was prepared by simple amide coupling following the previously reported 
method [18]. Surface modification of the prepared MoS2 nanosheets by PEI via thiol reaction where the 
sulfur moiety of the LA binds to the defect regions in the MoS2 nanosheets. Similarly, thiolated PEG is 
also grafted onto the surface of PEI-LA-MoS2 to form PEI-LA-MoS2-PEG (PMP) (Scheme S1c). The 
PMP and HA were mixed and sonicated and then EDC and NHS were added for activation and HA was 
grafted onto the surface region of the PMP by forming an amide bond between the carboxyl group of the 
HA and the amino group of the PMP to obtain nanocomposite HPMP (Scheme S1d). 
It can be seen from the TEM picture that the size of MoS2 nanosheets is ~50-80 nm (Fig. 1a). The 
XPS data of MoS2 show characteristic peaks at 517 eV (Mo3s), 413 eV (Mo 3p1), 359 eV (Mo 3p3), 
233eV (Mo 3d,) 64 eV (Mo 4s) and 38 eV (Mo 4p)(Fig. 1b). These XPS data are similar to other literature 
reports on MoS2 slices [46]. AFM imaging shows that the MoS2 nanosheets have a thickness of about 
1.8-2.2 nm, about 2 to 3 layers (Fig. 1c and d) [28]. The peaks at 2ɵ=14.28º, 33.54º and 58.96º were 
correspond to the (002), (100) and (110) planes of the hexagonal MoS2, respectively (Fig. 2a) [3]. Several 
distinct diffraction peaks of the sample matched with the standard patterns of the hexagonal MoS2 
(JCPDS 37–1492), indicating successful synthesis of MoS2 nanosheets [47]. The fabricated nanoplatform 
was further confirmed by FT-IR spectra (Fig. 2b) where the characteristic absorptions of PEI-LA-MoS2 
at 3415 cm-1, 2933cm-1 and 1642 cm-1 indicated the presence of -OH strand, CH2 asymmetric strand 
bending mode of the amino group (-NH2). Also, the peaks at 2856 cm-1 and 1628 cm-1 in HPMP can be 
attributed to the C-H strand the carbonyl-amide (-CO-NH-) vibration of HA. Formation of the stable 
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nanocomposites was further confirmed by DLSanalysis (Fig. 2c). After grafting the target molecule HA 
on the surface of MoS2 nanosheets by LA-PEI, the hydrodynamic diameter of the resulting HPMP is 104 
nm, which is increased compared to the bare MoS2 (80 nm). In addition, HPM without mPEG-SH 
modification and mPEG-SH modified HPMP were formulated into a certain concentration of aqueous 
solution to stand at room temperature. The results showed that HPMP had higher colloidal stability, and 
HPMP was still well dissolved in deionized water without being deposited after standing for 24 h (Fig. 
S1). Moreover, the zeta potential of the MoS2 nanosheets and HA was about -24 mV and -16 mV, 
respectively (Fig. 2d). Next, the LA-PEI was grafted on the surface of the MoS2 nanosheets by forming 
a disulfide bond, and the zeta potential of the particles was changed from -24 mV to +6 mV. The HA was 
further grafted by the formation of an amide bond, and the zeta potential of the HPMP nanoparticles was 
changed to -23 mV. In summary, the zeta potential change of the nanoparticles indicates that the targeting 
molecule HA is successfully bound to the surface of the MoS2 nanosheets. In addition, the successful 
loading of DOX and melanin on the nanocomposite HPMP was demonstrated by UV absorption 
spectroscopy (Fig. 3a and 3b). DOX exhibits an adsorption peak at 480 nm, which is also evident in the 
spectrum of HPMP@DOX. Melanin shows adsorption peaks at 258 nm and 369 nm, which are also 
evidented in the absorption spectrum of HPMP@(DOX/Mel), demonstrating the successful loading of 
melanin onto the nanocomposite HPMP@DOX. 
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Fig. 1. (a) TEM image of MoS2 nanosheets; (b) XPS survey spectrum of MoS2; (c) AFM images of the MoS2 
nanosheets and (d) the corresponding AFM height profile. 
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Fig. 2. (a) XRD pattern of the MoS2 nanosheets; (b) Infrared spectroscopy analysis of PEI-LA-MoS2 (red) and HPMP 
(blue); (c) Hydrodynamic diameters of MoS2 (black) and HPMP (red); (d) The zeta potential changes of nanoparticles 
are functionally modified to form HPMP processes. 
 
3.2. Photothermal activity 
First, the photothermal efficiency of HPMP@(DOX/Mel) and HPMP nanocomposites were 
determined. The HPMP@(DOX/Mel) composite was suspended in water at different concentrations and 
was irradiated with a 1.0 W cm-2 808 nm laser. As shown in Fig. 3c, the temperature of the 
HPMP@(DOX/Mel) aqueous solution increased with the concentration of the nanoparticles and the laser 
irradiation time. When the concentration of the HPMP@(DOX/Mel) nanocomposites was 0.8 mg mL-1, 
the temperature reached 52 °C within 300 s, indicating that the nanoparticles HPMP@(DOX/Mel) had a 
good photothermal effect. Also, the temperature increase was found to be directly related to laser power 
for HPMP@(DOX/Mel) aqueous solutions (Fig. 3d). Furthermore, the photostability of 
HPMP@(DOX/Mel) (1.0 mg mL-1) was also examined during four 1.0 W cm-2 laser irradiation on/off 
cycles and almost no noticeable attenuation could be observed in the temperature-time curve after the 
cycles (Fig. 3e). This implied that the HPMP@(DOX/Mel) nanocomposites had excellent photothermal 
stability and were suitable for photothermal ablation of tumors. More importantly, the temperature 
elevation for the HPMP@(DOX/Mel) nanoplatform was superior to that of HPMP under the same 
conditions, indicating a synergetic effect in the enhancement of photothermal efficiency due to the 
loading of Mel (Fig. 3f). Also, the photothermal conversion efficiency (η) of HPMP@(DOX/Mel) was 
calculated to be 55.3% according to the method reported in the literature (Fig. 3g and 3h) [44]. 
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Fig.3. (a) UV-Vis spectral analysis before and after HPMP loading DOX. (b) UV-Vis spectral analysis before and 
after HPMP@DOX loading of Mel. (c) Temperature increase of different concentrations of HPMP@(DOX/Mel) 
dispersions were irradiated with a 1.0 W cm-2 laser for 5 min. (d) Temperature increase of an 
HPMP@(DOX/Mel)dispersion (1.0 mg mL-1) at different laser power densities for 5 min. (e) Temperature plot of 
an HPMP@(DOX/Mel) dispersion (1.0 mg mL-1) irradiated by an 808 nm laser (1.0 W cm−2) for four on-off cycles. 
(f) Temperature increase of the nanocarrier before and after loading of Mel (1.0 W cm−2, 10 min). (g) Plot of 
temperature vs time for the HPMP@(DOX/Mel) during laser irradiation (808 nm, 1.5 W cm-2) and cooling (laser 
off) stages. (h) Linear time data versus ln(θ) obtained from the cooling period with laser off. (i) Release profiles from 
HPMP@DOX with or without 1.0 W cm-2 808 nm laser (irradiation times: 1h, 4h, 8h, 12h, 24h, 36h, 48h; pH 7.4 
and 5.0). 
 
3.3. In vitro pH/NIR -triggered drug release 
The optimum mass ratio of DOX to HPMP was first investigated at pH 7.4 and it was seen that the 
loading of DOX reached a maximum when the nanocomposite HPMP was mixed with DOX in a ratio of 
1:1. Thus, DOX (944.3 mg) could be loaded onto HPMP (1 g) (Table S1). The in vitro drug release of 
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HPMP@DOX was then investigated in PBS buffers at pH 7.4 and 5.0 with and without 808 nm laser 
irradiation. As shown in Fig.3i, the DOX released from the HPMP@DOX was less than 5% at pH 7.4 
after 1 h, however, the release of DOX exceeded 12% at pH 5.0 after 1 h. These results may be due to 
the decrease of the hydrophobic interaction and electrostatic interaction forces between the DOX and 
HPMP nanocomposites, which can dramatically accelerate DOX release. Next, the influence of laser 
irradiation on HPMP@DOX drug release was further studied (Fig. 3i). At pH 5.0, without NIR laser 
irradiation, HPMP@DOX released about 24.8% of DOX within 6 h, however, when irradiated with a 1.5 
W cm-2 808 nm laser at pH 5.0, the amount of DOX released from HPMP@DOX increased to 31.6%. In 
summary, the NIR-triggered nanoparticle photothermal effect could accelerate the release of DOX drugs 
in HPMP@DOX. This may be due to the high temperatures generated by the MoS2 nanosheets causing 
vibration of the HPMP nanocomposite, thereby reducing the interaction between DOX and the 
nanoplatform [18, 47]. Taking into account that laser irradiation can be adjusted accurately, the pH/NIR 
multiple-stimuli-responsive HPMP@(DOX/Mel) are expected to be applied to “on demand” 
chemotherapy of cancer. 
 
3.4. In vitro cell viability 
It is well known that the cytocompatibility of nanocarriers is critical for an ideal drug delivery system. 
Therefore, the cell viability of HPMP-treated MCF-7 and L929 cells was investigated by MTT. After 
incubation for 48 h with different concentrations of HPMP nanocomposites, the overall viability remains 
above 95% at the highest HPMP concentration tested, confirming that the HPMP possess an excellent 
cytocompatibility in the given concentration range (Fig. S2). 
The therapeutic efficacy was evaluated by comparing cell viabilities after incubating L929 and MCF-
7 cells with culture medium, free DOX, HPMP@DOX, HPMP@Mel with NIR laser irradiation, 
HPMP@DOX with NIR laser irradiation, and HPMP@(DOX/Mel) with or without NIR laser irradiation 
(Fig. 4a and 4b). Compared to the separate free DOX treatment group, the cell viability of L929 cells in 
the HPMP@DOX treatment group (DOX concentration: 1.5 μg mL−1) was significantly increased. 
However, for MCF-7 cells, the results were reversed, which indicated that the nanocarrier loading of 
DOX enhanced the chemotherapeutic effect on tumor cells. It was also found that under near-infrared 
light irradiation, the cell viability of both groups treated with HPMP@Mel decreased and the activity of 
the MCF-7 cell group was the lowest, indicating that the nanocomposite loaded with Mel had a good 
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photothermal treatment effect on tumor cells. It is worth noting that the external stimulation with near-
infrared light can not only achieve the purpose of photothermal treatment to kill cancer cells, but also 
promotes the release of the chemotherapeutic drug DOX from the nanocarriers, thereby enhancing the 
effect. This can be attributed to the thermal energy generated by near-infrared light stimulation that 
disrupts the π-π stacking effect between DOX and the nanocarrier HPMP [48]. 
Finally, under the conditions of near-infrared light irradiation, the cell viability of the two groups of 
cells treated with (PMP@(DOX/Mel), HPMP@DOX and HPMP@(DOX/Mel) was studied. MCF-7 cells 
treated with HPMP@(DOX/Mel) showed the lowest cell viability compared to the two groups treated 
with PMP@(DOX/Mel) and HPMP@DOX. This indicated that the loading of Mel significantly 
enhanced the synergistic therapeutic effect of photothermal therapy and chemotherapy to tumor cells and 
the synergistic therapeutic effect of tumor cells is significantly better than any single therapy such as 
chemotherapy or photothermal therapy alone. In addition, the loading of the targeting molecule 
hyaluronic acid allowed the nanocomplex to be selectively taken up by tumor cells. All the results showed 
that the prepared nanocomposite HPMP@(DOX/Mel) can effectively concentrate photothermal therapy 
and chemotherapy into a multifunctional drug delivery system, greatly improving the killing effect on 
tumor cells. 
 
Fig. 4. Relative cell viability of (a) L929 cells and (b) MCF-7 cells incubated with DOX or the different 
nanocomposite with a DOX concentration of 1.5–24 μg mL-1 for 48 h. *P < 0.05, **P < 0.01, and ***P < 0.001. 
 
3.5. Cellular uptake 
The active targeting effect of HA-modified nanocomplexes to cancer cells was studied using CLSM. 
MCF-7 cells (CD44 receptor positive) were selected as model cancer cells and the free DOX treated 
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group was used as a control. As shown in Fig. 5, MCF-7 cells treated with HPMP@(DOX/Mel) (targeting 
group) showed brighter DOX fluorescence compared to PMP@(DOX/Mel) (non-targeted group) cells, 
indicating that the uptake behavior of HPMP@(DOX/Mel) in MCF-7 cells is associated with CD44 
receptor-mediated endocytosis pathway. Also, MCF-7 cells treated with HPMP@(DOX/Mel) under near-
infrared laser irradiation had a stronger DOX fluorescence than other treatment groups and can be 
attributed to the local high temperature-induced cell membrane damage caused by MoS2 and Mel under 
near-infrared laser irradiation, which increases the uptake of nanocomplexes by the MCF-7 cells [49]. 
The quantitative flow cytometry measurement further confirmed that the cellular uptake of the 
nanoplatform (Fig. 6). It is concluded that HA-modified nanocomplexes can specifically deliver DOX to 
MCF-7 cells via the CD44 receptor-mediated endocytic under NIR laser irradiation, thereby increasing 
the cancer chemotherapy-photothermal synergistic treatment effect. 
 
Fig. 5. Confocal microscope images of MCF-7 cells treated with free DOX, PMP@(DOX/Mel), HPMP@(DOX/Mel) 
and HPMP@(DOX/Mel) with laser irradiation for 30 min at an equivalent DOX concentration of 5.0 μg mL-1 for 4 
h. Scale bar: 25 μm. 
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Fig. 6. Flow cytometry data for (a) untreated MCF-7cells (b) Free DOX or (c) PMP@(DOX/Mel) (d) 
HPMP@(DOX/Mel) (e) HPMP@(DOX/Mel) +NIR. (f) The relative fluorescence intensity values calculated from 
panels (a–e). The data are represented as mean ± S.D. (n = 3). ***P < 0.001. 
3.6. Antitumor effect in vivo 
Encouraged by the attractive ability of Mel-triggered enhanced photothermal conversion efficiency 
of nanoparticles and the dual-responsive drug release shown above with HPMP@(DOX/Mel), the in vivo 
photothermal performance and antitumor effects of HPMP@(DOX/Mel) were investigated. Fig. 7a 
shows the temperature change of the tumor region during the 808 nm laser irradiation of the tumor-
bearing mice of the different treatment groups as recorded by a thermal camera. For mice injected with 
just saline, only a slight temperature change was observed at the tumor site. For the HPMP@DOX treated 
mice, the temperature of the tumor site reached 43 °C within 8 min 808 nm laser irradiation. Compared 
with the above two groups, the temperatures of the HPMP@(DOX/Mel) group were raised to 48 °C (Fig. 
7b), which was sufficient to ablate the tumor tissue. From the photographs of the tumors excised from 
the experimentally treated mice (Fig. 7c), it can be seen that the size of the tumors injected with 
HPMP@(DOX/Mel) is obviously smaller than that of the other treatment groups under near-infrared 
light. Meanwhile, the relative tumor volume (V/V0) curves of tumor-bearing mice after different 
treatments are shown in Fig. 7d. In particular, compared with the other treatment groups, the injection of 
HPMP@(DOX/Mel) group under the near-infrared laser irradiation can effectively inhibit the growth of 
mouse tumors, indicating that the killing effect on cancer cells is significantly enhanced due to the 
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synergistic effect of chemotherapy and photothermia and the active targeting of HA. Interestingly, the 
chemotherapy groups (HPMP@(DOX/Mel), free DOX, or photothermal therapy (HPMP@Mel with 
laser irradiation) also inhibited tumor cell growth to some extent, but these were not as effective as the 
synergistic treatment group. Also, the killing effect of HPMP@DOX and NIR irradiation groups on 
tumor cells is not as good as that of the HPMP@(DOX/Mel) plus NIR irradiation group, indicating the 
loading of melanin significantly improves the effectiveness of the photothermal ablation. In addition, the 
body weight of the mice in the HPMP@(DOX/Mel) plus NIR irradiation group was well maintained, 
similar to the other groups, indicating that the HPMP@(DOX/Mel)NPs had very little negative side 
effects (Fig. 7e). 
 
Fig.7. (a) Photothermal images ((I). Saline; (II). HPMP@(DOX)+NIR; (III). HPMP@(DOX/Mel)+NIR) and (b) 
corresponding temperature profile of tumor sites over time after treatment of MCF-7 tumor-bearing mice with Saline、 
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HPMP@(DOX ) or HPMP@(DOX/Mel) under 808 nm laser irradiation ( 0.8 W cm-2). (c) Photographs of the tumors 
dissected from the mice at the end of each treatment. (d) Relative tumor growth curves of the five groups after 
various treatments (n = 5); *P < 0.05, **P < 0.01, and ***P < 0.001. (e) Body-weight curves of mice after different 
treatments.  
 
3.7. Histology analysis 
Histology analysis, including hematoxylin and eosin (H&E) staining and terminal deoxynucleotidyl 
transferase-mediated dUTP nickend labeling (TUNEL) in tumor tissues were conducted (Fig. 8a). As 
shown by the H&E stained tumor sections, the HPMP@(DOX/Mel) + laser group has only a small 
fraction of purple-blue (normal nucleus) and more deformed nuclei (nuclear pyknosis, nuclear rupture 
and nuclear lysis), indicating that cancer cells are highly apoptotic. From the results of the TUNEL 
measurements, the dark brown nuclei in the HPMP@(DOX/Mel) + laser group indicate apoptosis-
positive cells. In summary, synergistic chemo-photothermal treatment assisted by HPMP@(DOX/Mel) 
shows a good therapeutic effect in vivo. Furthermore, the main organs (heart, lung, liver, spleen, and 
kidney) of the mouse were taken out after the treatment and sectioned for H&E staining examination 
(Fig. 8b). No significant histopathological damage was shown in these tissues, demonstrating that the 
synergistic treatment had little adverse effects on the normal organs of the mice, which confirmed the 
negligible long-term toxicity of the material. 
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Fig.8. (a) H&E staining and TUNEL staining of tumor sections after various treatments. (b) Representative H&E 
sections of major organs (heart, liver, spleen, lung and kidney) of MCF-7 tumor-bearing nude mice after various 
treatments (I. Saline; II. Free DOX ; III. PMP@(DOX/Mel)+NIR; IV. HPMP@(DOX/Mel);V. HPMP@(DOX/Mel) 
+ NIR. All the scale bars are 50 μm.) 
 
4. Conclusions 
A new multifunctional HPMP@(DOX/Mel) nano-platform was successfully synthesized and the 
synergistic chemo-photothermal therapy was studied. First, the MoS2 nanosheets were functionalized 
with biodegradable hyaluronic acid (HA) in the presence of polyethyleneimine (PEI), while the MoS2 
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nanosheets were modified with mPEG-SH to achieve better biocompatibility under physiological 
conditions. The chemotherapeutic drug DOX and the photothermal agent melanin were then 
simultaneously loaded onto the HPMP nanocarrier to study the effect of synergistic chemo-photothermal 
therapy. The prepared HPMP nanocomposite has a uniform particle size (104 nm), a high drug loading 
(944.3 mg.g-1 HPMP), excellent biocompatibility and good thermal properties (photothermal conversion 
efficiency: 55.3%). The resulting versatile platform showed the following characteristics: (1) high load 
efficiency of DOX; (2) the payload of endogenous bio-pigment melanin greatly improved the 
photothermal conversion effect of the nanocomposite HPMP; (3) the nanocomplex was specifically 
delivered into MCF-7 cells by an endocytosis pathway mediated via the HA-targeted CD44 receptors; 
(4) the loaded chemotherapeutic drug DOX showed a significant double-stimulated response release 
when irradiated with light at 808 nm in the weakly acidic environment of tumor cells. Overall, the results 
of animal experiments indicated that the chemical photothermal synergy therapy of HPMP@(DOX/Mel) 
had an excellent therapeutic effect compared to single therapy. Therefore, this new multifunctional nano-
platform is promising as a multi-modal anti-tumor drug delivery system in the biomedical field. 
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